These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 3895919)

  • 1. Role of cephalosporins in the treatment of bacterial meningitis in adults. Overview with special emphasis on ceftazidime.
    Norrby SR
    Am J Med; 1985 Aug; 79(2A):56-61. PubMed ID: 3895919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of newer cephalosporins into cerebrospinal fluid.
    Cherubin CE; Eng RH; Norrby R; Modai J; Humbert G; Overturf G
    Rev Infect Dis; 1989; 11(4):526-48. PubMed ID: 2672238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cephalosporins in the treatment of meningitis.
    Neu HC
    Drugs; 1987; 34 Suppl 2():135-53. PubMed ID: 3319497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of cephalosporins in bacterial meningitis.
    Nelson JD
    Am J Med; 1985 Aug; 79(2A):47-51. PubMed ID: 3849260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third-generation and investigational cephalosporins: II. Microbiologic review and clinical summaries.
    Garzone P; Lyon J; Yu VL
    Drug Intell Clin Pharm; 1983 Sep; 17(9):615-22. PubMed ID: 6311502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cephalosporin compounds in severe neonatal infection.
    Schaad UB
    Eur J Pediatr; 1984 Jan; 141(3):143-6. PubMed ID: 6321189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapeutic properties of the new cephalosporin antibiotic HR810 in laboratory animals.
    Klesel N; Limbert M; Schrinner E; Seeger K; Seibert G; Winkler I
    Infection; 1984; 12(4):286-92. PubMed ID: 6092278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis.
    Scheld WM; Rocha H; Sande MA; Bryan JP
    Am J Med; 1984 Oct; 77(4C):42-9. PubMed ID: 6093518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of first, second and third generation cephalosporins.
    Forsgren A
    Acta Pathol Microbiol Scand B; 1981 Aug; 89(4):221-5. PubMed ID: 6274143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial meningitis: is there a "best" antimicrobial therapy?
    Eichenwald HF
    Eur J Pediatr; 1987 May; 146(3):216-20. PubMed ID: 3297707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serious pediatric infections.
    Kaplan SL
    Am J Med; 1990 Apr; 88(4A):18S-24S. PubMed ID: 2183605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime and cefotaxime--the clinician's choice.
    Puthucheary SD; Goldsworthy PJ
    Clin Ther; 1989; 11(2):186-204. PubMed ID: 2660995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis.
    Landesman SH; Corrado ML; Shah PM; Armengaud M; Barza M; Cherubin CE
    Am J Med; 1981 Oct; 71(4):693-703. PubMed ID: 6269429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic studies of cefepime (BMY 28142) in murine meningitis and pharmacokinetics in neonatal rats.
    Tsai YH; Bies M; Leitner F; Kessler RE
    Antimicrob Agents Chemother; 1990 May; 34(5):733-8. PubMed ID: 2360814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
    McCracken GH; Nelson JD; Grimm L
    Antimicrob Agents Chemother; 1982 Feb; 21(2):262-7. PubMed ID: 6280599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA; Day GJ; Humble MW
    N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of gram-negative bacterial meningitis in term neonates with third generation cephalosporins plus amikacin.
    Dellagrammaticas HD; Christodoulou C; Megaloyanni E; Papadimitriou M; Kapetanakis J; Kourakis G
    Biol Neonate; 2000 Mar; 77(3):139-46. PubMed ID: 10729716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Third generation cephalosporins (cefoperazone, cefotaxime, ceftazidime and ceftriaxone) in the prevention and treatment of experimental plague in albino mice].
    Ryzhko IV; Tsuraeva RI; Pasiukov VV; Samokhodkina ED; Shcherbaniuk AI
    Antibiot Khimioter; 1996 May; 41(5):35-8. PubMed ID: 9054316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.